Analysis of Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners - aVenture Research
Microbiome Times Magazine - Reporting on The Latest Microbiome Business & Scientific Developments
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid human health, announced today it has raised $11.2M in a Series A financing led by S2G Ventures and Bold Capital Partners, along with continued investment from Viking Global and additional investment from the Gisev Family Office as a syndicate investor. Solarea
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.